Future longitudinal follow‐up in combination with cerebrospinal fluid or brain tissue sample, and as well as in vitro and animal studies will reveal the causal role of ApoE ε4, GSK‐3β and the cognitive functions in T2DM patients. The gene discussed is GSK3B; the disease is type 2 diabetes mellitus.